Stockscreener 앱 받기
7.87
7.51%
0.55
시간 외 거래:
7.97
0.10
+1.27%
전일 마감가:
$7.32
열려 있는:
$7.38
하루 거래량:
295.02K
Relative Volume:
0.96
시가총액:
$146.70M
수익:
$62.81M
순이익/손실:
$-13.75M
주가수익비율:
-9.8375
EPS:
-0.8
순현금흐름:
$153.00K
1주 성능:
+1.03%
1개월 성능:
-28.58%
6개월 성능:
-57.71%
1년 성능:
+49.05%
1일 변동 폭
$7.20
$7.96
1주일 범위
$6.84
$8.06
52주 변동 폭
$3.9914
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
명칭
Optimizerx Corp
전화
248-651-6558
주소
260 CHARLES STREET, WALTHAM, MI
Compare OPRX vs VEEV, TEM, BTSG, HQY, WAY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
7.87 | 136.45M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
188.48 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
51.29 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.96 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
81.15 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.93 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-08 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-07-25 | 재개 | B. Riley Securities | Buy |
| 2024-04-04 | 개시 | JMP Securities | Mkt Outperform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-02-02 | 재개 | B. Riley Securities | Buy |
| 2022-11-01 | 개시 | Stifel | Buy |
| 2022-07-15 | 개시 | SVB Leerink | Outperform |
| 2021-10-18 | 재개 | B. Riley Securities | Buy |
| 2021-04-13 | 개시 | RBC Capital Mkts | Outperform |
| 2019-01-03 | 개시 | William Blair | Outperform |
모두보기
Optimizerx Corp 주식(OPRX)의 최신 뉴스
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
OptimizeRx Corp expected to post earnings of 23 cents a shareEarnings Preview - TradingView
OPRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Portfolio Update: Can OptimizeRx Corporation weather a recessionJuly 2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
OptimizeRx (OPRX) Projected to Post Quarterly Earnings on Thursday - Defense World
Can OptimizeRx Corporation sustain earnings growthQuarterly Trade Review & Breakout Confirmation Alerts - mfd.ru
Is OptimizeRx Corporation stock trending bullishPortfolio Return Summary & Step-by-Step Trade Execution Guides - mfd.ru
CenterBook Partners LP Invests $6.33 Million in OptimizeRx Corp. $OPRX - MarketBeat
OptimizeRx (OPRX): Small-Cap AI Health Stock Quietly Repricing Higher - AD HOC NEWS
US Market Recap: Can OptimizeRx Corporation maintain sales growthEarnings Beat & Long-Term Growth Plans - baoquankhu1.vn
Brokerages Set OptimizeRx Corp. (NASDAQ:OPRX) Price Target at $21.00 - Defense World
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Portfolio Update: Can OptimizeRx Corporation sustain earnings growth2025 Price Targets & Daily Volume Surge Trade Alerts - baoquankhu1.vn
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET - The Manila Times
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial - GlobeNewswire
Strength Seen in OptimizeRx (OPRX): Can Its 7.5% Jump Turn into More Strength? - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Stock Price Down 6.1%Here's What Happened - MarketBeat
Day Trade: Can OptimizeRx Corporation ride the EV waveJuly 2025 Review & Expert Verified Stock Movement Alerts - baoquankhu1.vn
How Evolving Valuation Assumptions Are Rewriting The Story For OptimizeRx (OPRX) - Yahoo Finance
Market Outlook: Will OptimizeRx Corporation benefit from sector rotation2025 Risk Factors & AI Powered Trade Plan Recommendations - baoquankhu1.vn
OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Is OptimizeRx Corporation stock attractive after correctionSell Signal & Daily Profit Maximizing Trade Tips - Улправда
OptimizeRx (OPRX): Clinical Network Growth Drives 37% Reach Boost Amid Analyst Upgrades - Finviz
9 Best Performing Micro Cap Stocks in 2025 - Insider Monkey
OptimizeRx and Experian collaborate to improve privacy-safe identity resolution in healthcare marketing - MarketScreener
OptimizeRx Corp. and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing - marketscreener.com
OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing - The Manila Times
Best Growth Stocks to Buy for July 22nd - MSN
Head to Head Comparison: Manhattan Associates (NASDAQ:MANH) and OptimizeRx (NASDAQ:OPRX) - Defense World
OptimizeRx (NASDAQ:OPRX) Insider Sells $18,751.88 in Stock - MarketBeat
OptimizeRx CFO sells $18,751 in shares By Investing.com - Investing.com Nigeria
OptimizeRx CFO sells $18,751 in shares - Investing.com
OptimizeRx Corp Executive Sells Shares - TradingView — Track All Markets
How OptimizeRx Corporation stock responds to policy changesMarket Rally & Stepwise Trade Signal Implementation - Улправда
Is OptimizeRx Corporation stock oversold or undervaluedRecession Risk & AI Forecast for Swing Trade Picks - Улправда
Is OptimizeRx Corporation stock a good choice for value investors2025 EndofYear Setup & High Accuracy Investment Signals - DonanımHaber
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
OptimizeRx (NASDAQ:OPRX) Cut to “Hold” at Zacks Research - Defense World
OptimizeRx (NASDAQ:OPRX) Cut to "Hold" at Zacks Research - MarketBeat
OPRX FinancialsIncome Statement - Quiver Quantitative
OptimizeRx Corp. Expands Point-of-Care Network with Four New Partner Agreements - Quiver Quantitative
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network - The Manila Times
New partnerships plug drug makers into more doctors’ EHR workflows - Stock Titan
Officer D'Silva Surrenders 868 Of OptimizeRx Corp [OPRX] - TradingView — Track All Markets
OptimizeRx Corp (OPRX) insider has 868 shares withheld for taxes - Stock Titan
Wall Street Zen Upgrades OptimizeRx (NASDAQ:OPRX) to “Strong-Buy” - Defense World
Wall Street Zen Upgrades OptimizeRx (NASDAQ:OPRX) to "Strong-Buy" - MarketBeat
Looking at the Narrative for OptimizeRx After Guidance Boost and Recurring Revenue Shift - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Cut to "Buy" at Wall Street Zen - MarketBeat
Optimizerx Corp (OPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.25%
1.11%
자본화:
|
볼륨(24시간):